United States

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

11:35am EDT
Change (% chg)

€-0.17 (-0.22%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for FREG.DE


Fresenius SE & Co KGaA is a health care company. It operates in the healthcare sector and offers products and services for dialysis, hospitals and outpatient medical care. It focuses on the hospital operations and offers engineering and services for hospitals and other health care facilities. The Company’s operating segments... (more)


Beta: 0.60
Market Cap(Mil.): €42,066.66
Shares Outstanding(Mil.): 553.65
Dividend: 0.62
Yield (%): 0.82


  FREG.DE Industry Sector
P/E (TTM): 25.31 30.58 17.29
EPS (TTM): 3.00 -- --
ROI: 8.96 6.70 -5.84
ROE: 13.40 10.17 -5.23

BRIEF-Cerus provides U.S. business update

* A pending platelet additive solution shortage is expected to impact some U.S. blood centers producing intercept platelets

8:45am EDT

REFILE-Fresenius vows to take breather after three deals

FRANKFURT, May 12 The head of German healthcare group Fresenius SE said he would abstain from the takeover market for now, after striking three deals worth billions of euros in total since taking over less than a year ago.

May 12 2017

Fresenius ups guidance on growth at generic drugs unit

FRANKFURT German healthcare group Fresenius on Wednesday toned up its earnings guidance for the year as demand for recently launched generic infusion drugs continued to grow at higher-than-expected rates.

May 03 2017

UPDATE 1-Fresenius ups guidance on growth at generic drugs unit

* Unit FMC shored up by reimbursement, drug cost control (Adds FMC results, premarket shares)

May 03 2017

Fresenius ups FY guidance on growth at generic drugs unit

FRANKFURT, May 3 German healthcare group Fresenius SE & Co KGaA on Wednesday lifted its guidance on strong demand in the United States for its generic infusion drugs.

May 03 2017

LPC: US loan market welcomes M&A surge

NEW YORK, April 28 US companies have lined up at least US$42.5bn of loans to back a flurry of mergers in sectors ranging from healthcare to food and software in the second quarter as corporations try to grow by acquisition.

Apr 28 2017

UPDATE 1-Fresenius poaches Telefonica Deutschland CFO -Manager Magazin

* Telefonica D. says Empey's contract runs until end-2018 (Adds comment from Telefonica Deutschland, details on Empey's career)

Apr 27 2017

BRIEF-Telefonica Deutschland says its CFO has a contract through end-2018

April 27 Telefonica Deutschland in response to Manager Magazin report saying CFO Rachel Empey will be named new CFO of Fresenius

Apr 27 2017

Fresenius poaches Telefonica Deutschland CFO -Manager Magazin

FRANKFURT, April 27 Fresenius has tapped Telefonica Deutschland finance chief Rachel Empey to fill the same position at the diversified German healthcare group, monthly Manager Magazin cited sources as saying on Thursday.

Apr 27 2017

Fitch: Fresenius Deals Offer Growth, Diversification; No Rating Impact

(The following statement was released by the rating agency) LONDON, April 26 (Fitch) Fitch Ratings says transactions by German healthcare group Fresenius SE & Co KGaA (FSE; BBB-/Stable) - including Fresenius Medical Care AG & Co. KGaA (FMC; together, Fresenius) - that enable its diversification into US generics through Akorn and biosimilars through Merck, will enhance its business risk profile. The group is well anchored in investment-grade territory, although the transactions will exhaust any f

Apr 26 2017

More From Around the Web

Earnings vs. Estimates